Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, a challenging macroeconomic scenario continues to plague Globus Medical. The stock ...

Globus Medical has completed its acquisition of the US-based medical device company Nevro, broadening its market presence in ...

In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...

Learn more about whether Globus Medical, Inc. or Inspire Medical Systems, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers ...

Globus Medical, Inc. (NYSE:GMED – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the company, Marketbeat reports. Three ...

Globus Medical GMED recently launched the COHERE ... which is an extension of the widely recognized Modulus ALIF interbody spacer system. The new offerings are designed to address a variety ...

Globus Medical Inc is a medical device company ... which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated ...

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...